Back to MW MARSHALL WACE, LLP

ATYRATYR
Showing 7 of 17 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ATYR PHARMA INC

MARSHALL WACE, LLP holds 368,120 shares of ATYR (ATYR PHARMA INC), worth $220,872 as of 2026-Q2. The position was increased (+166.5% shares). ATYR represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$220,872

Current Shares

368,120

Total Value Change

+$196,177

Total Shares Change

+354,089

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
368,120
+166.5%
$220,8720.0%$0.60
37
2026-Q1
New
138,118
-
$107,7330.0%$0.96
30
2025-Q3
Exited
0
-100.0%
$00.0%$0.80
0
2025-Q2
Decreased
511,412
-39.0%
$2.6M0.0%$5.03
0
2025-Q1
New
838,452
-
$2.5M0.0%$3.13
36
2024-Q4
Exited
0
-100.0%
$00.0%$3.51
0
2024-Q3
New
14,031
-
$24,6950.0%$1.77
29

Other major holders of ATYR: FEDERATED HERMES, INC., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used